Dr. Parulekar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1161 21st Avenue South
T-1218 Medical North
Nashville, TN 37232- Is this information wrong?
Education & Training
- IU Kelley School of BusinessMBA, 2018 - 2020
- Baylor College of Medicine School of Biomedical SciencesMS, 2013 - 2017
- Washington University/B-JH/SLCH ConsortiumFellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
- Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2004 - 2007
- University of Missouri Kansas City School of MedicineClass of 2004
- University of Missouri - Kansas CityB.A., 2003
Certifications & Licensure
- TX State Medical License 2010 - 2025
- TN State Medical License 2019 - 2022
- AL State Medical License 2020 - 2020
- MO State Medical License Active through 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Efficacy and Safety of Beta-adrenoceptor Inverse Agonist, Nadolol, in Mild Asthma Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- Burnout Syndrome in Lung Transplant Physicians.Christina C Kao, Gloria W Li, Amit D Parulekar> ;Clinical Medicine & Research. 2023 Jun 1
- Comparison of four commercial EBV DNA quantitative tests to a new test at an early stage of development.Evelyn Stelzl, Harald H Kessler, Amit D Parulekar, Carolin Bier, Dominik Nörz, Tanja Schneider, Suchitra Kumar, Christian O Simon, Marc Lütgehetmann> ;Journal of Clinical Virology. 2023 Apr 1
- 7 citationsEmphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort.Vickram Tejwani, Ashraf Fawzy, Nirupama Putcha, Peter J. Castaldi, Michael H. Cho, Katherine A. Pratte, Surya P. Bhatt, David A. Lynch, Stephen M. Humphries, Gregory L...> ;Chest. 2021 Oct 1
- Join now to see all
Press Mentions
- © Journal of Thoracic Disease. All Rights Reserved. J Thorac Dis 2019;11(Suppl 14):S1782-S1788 | http://dx.doi.org/10.21037/jtd.2019.05.60April 2nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: